Navigation Links
Feds Might 'Banish' More Execs for Misconduct, Attorney Says
Date:7/5/2011

ad use of such tactics would amount to nothing less than a game-changer, Ortiz noted. "But officials at HHS and the Department of Justice are increasingly vocal about the need to punish individual executives, even if extraordinary means are required," he said, "so that might well be what they have in mind." Indeed, the attorney noted, at the 21st Annual Institute on Health Care Fraud, a major symposium held in Miami Beach in mid-May, regulators were unambiguous about their intent to step up enforcement actions against individuals.

"In its initial crackdown on the likes of off-label marketing or violations of the Foreign Corrupt Practices Act, the government dramatically increased fines and penalties, such that damages totaling hundreds of millions or even billions of dollars are not uncommon today," said Washington, D.C.-based LeClairRyan shareholder Michael F. Ruggio. "When misconduct persisted despite these massive penalties, regulators sharpened their focus on indictments of individual corporate executives. However, proving such cases beyond a reasonable doubt can be difficult, and successful prosecutions are relatively rare. Thus, it is entirely possible that extrajudicial tactics could become more commonplace."

The government might use the disbarment provision to go after individual executives it suspects of turning a blind eye toward regulatory violations, maintaining lax internal controls and otherwise "setting the wrong tone at the top," Ortiz said. No forewarning would be required.

Once a clear pattern emerges regarding the intended use of the disbarment provision, regulated companies will need to work with their outside counsel to adjust their legal strategies as required, he advised. Before reaching a settlement agreement in a criminal case, for example, companies might secure written assurances that regulators will not try to use the disbarment provision later on.

Likewise, the threat of these extrajudicial powers underscore
'/>"/>

SOURCE LeClairRyan
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Most Women With HIV and Their Health Care Providers Have Not Discussed How HIV Might Affect Them Differently Than Men
2. St. Jude Study Finds Treatment With New Drug Might Make Tumor Cells More Sensitive to Therapy
3. Aching Back? Cholesterol Medication Might Help
4. If You Bought ExtenZe, You Might Receive Money and Benefits from a Class Action Settlement.
5. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
6. Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee
7. Whistleblowers Attorney Says Pfizers Guilty Plea Today Opens New Chapter on Aggressive Enforcement of Pharma Companies
8. Relators Attorneys Comment On AtriCure/DOJ Proposed Settlement
9. Remarks as Prepared for Delivery By Attorney General Eric Holder at the AstraZeneca Settlement Announcement
10. Fort Worth Attorney Dwain Dent Comments on Final Judgment in Case That Left Hundreds of Babies Dead or Injured
11. Lead Plaintiffs Attorney In Forest Pharmaceuticals Case Says $313 Million Award Is Tip of the Iceberg of Future Off-Label Marketing Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013  Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... at the UBS Global Healthcare Conference in New ... 22 nd at 11 a.m. Eastern Time. To listen ... please visit the Investor Relations section of the Company,s Web ... for 14 days after the event. About Orexigen® ...
(Date:5/17/2013)... Biotechnology Inc. ("Sony") today announced the launch of the new ... Sony will also be exhibiting its newly rebranded reagent portfolio. ... EC800 flow cytometer, and new SP6800 Spectral Analyzer will be ... held at the San Diego Convention ... May 20 - 22.  The 8-well strip ...
(Date:5/17/2013)... Research explores data on ... also   to   be presented ... the global specialty biopharmaceutical company, announces that it will ... American Psychiatric Association (APA) 166th Annual Meeting in ... being presented represent Shire,s ongoing commitment to the clinical ...
Breaking Medicine Technology:Sony Delivers New Technology for Science to CYTO 2013 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10
... increasingly are applying genomics technologies to toxicology research to ... a variety of organ systems, reports Genetic Engineering ... especially interested in figuring out a new compound,s mechanism ... according to the November 15 issue of GEN ...
... Nov. 18 Arlington Medical Resources (AMR), a,provider of ... finds that over $10 million of CSL Behring,s Privigen ... 2008. Privigen is the newest,brand of intravenous immune globulin ... IVIG is a product created from the blood plasma ...
Cached Medicine Technology:GEN Reports on the Trend Toward Predictive Toxicogenomics 2Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2
(Date:5/18/2013)... FL (May 18, 2013) There are significant ... commonly used to diagnose or treat gastrointestinal problems, ... (DDW). , A study by New York ... more objective testing may substantially reduce the cost ... Although GERD is believed to affect nearly 25 ...
(Date:5/18/2013)... May 18, 2013 Today, Zane ... insurance agents’ role in Marketplaces . Zane Benefits, ... employer sponsored health benefits, is the leader in ... health reimbursement arrangements . , According to ... Human Services (HHS) recently released a much-anticipated statement ...
(Date:5/18/2013)... NY (PRWEB) May 18, 2013 After working ... efforts, SizeItUp formally announced the integration of the ... 2012 Hyundai Genesis is set to stun the automobile market ... style. 2012 Hyundai Genesis is marked as the latest entry ... heads the vehicles lined up for the year 2013. ...
(Date:5/18/2013)... AL (PRWEB) May 18, 2013 Although ... malignant tumors, the association between obesity and esophageal adenocarcinoma, ... for other obesity-related tumors. As reported on ... people are almost twice as likely as those of ... Although the relationship between obesity and esophageal cancer is ...
(Date:5/18/2013)... May 18, 2013 Show And Go Training, ... various different training systems that is all about is getting ... the attention of http://ShowAndGoTrainingReview.com ’s Stan Stevenson, prompting ... is a unique “four phase system” designed to make you ... of time spent working out in the gym. The training ...
Breaking Medicine News(10 mins):Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2
... for Everyone , Not all patients can tolerate ... can help physicians calculate the epirubicin dose associated with ... , Oncologists frequently use anthracyclines, including epirubicin and doxorubicin, ... lasting heart problems in a substantial number of patients. ...
... 6.9 percent sequentially - Q2 GAAP net profit ... - Case shipments of 54,870 increase 6.0 percent sequentially ... SANTA CLARA, Calif., July 29 Align,Technology, Inc. (Nasdaq: ALGN ... ended June 30, 2008., Total net revenues for the second ...
... projected ... ... of,high-quality ceramic solutions for the medical device industry, announced,today that, in ... on unit shipments to the orthopaedic,brachytherapy and electro-implantable market segments., ...
... FACP, FACEP (E), Executive,Director, American Public Health Association, ... Association strongly urges U.S. House members to vote ... Food and Drug Administration (FDA),the authority to regulate ... for more than 400,000 deaths each,year and costs ...
... of matted protein, researchers say , , TUESDAY, July 29 (HealthDay ... clogging "tangles" in the brain cells of people with Alzheimer,s ... studies are necessary to confirm whether the medication is as ... needs to be given as part of a cocktail of ...
... ... Future Costs Can Be Avoided with Proper Treatment and Prevention ... Initiatives, NEW BRUNSWICK, N.J., ... on New,Jersey,s economy of the most common chronic diseases is calculated to be,$39 billion. In ...
Cached Medicine News:Health News:Also in the July 29 JNCI 2Health News:Also in the July 29 JNCI 3Health News:Also in the July 29 JNCI 4Health News:Also in the July 29 JNCI 5Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 2Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 3Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 4Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 5Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 6Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 7Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 8Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 9Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 10Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 11Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 12Health News:Align Technology Announces Second Quarter Fiscal 2008 Results 13Health News:C5 Medical Werks Reaches Million Mark in Components Shipped 2Health News:'De-Tangling' Alzheimer's Drug Shows Promise 2Health News:'De-Tangling' Alzheimer's Drug Shows Promise 3Health News:'De-Tangling' Alzheimer's Drug Shows Promise 4Health News:Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion 2Health News:Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion 3Health News:Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion 4
Classic Trial Frames UB3 that has long set the standard....
... This quality Universal Trial Frame comes at a very attractive ... Temple angle, Temple length 4 1/8" to 5 1/2" ... angle 0 to 30, PD adjustable 24 to 40mm ... Axial calibration on each lens: left - 120 to 0 ...
Sickle blade. Flat stock myringotomy blade....
... offer the superior cutting advantages of ... the exclusive Rib-Back design for greater ... producer offer the wide selection of ... Every blade is packaged in a ...
Medicine Products: